Skip to content

Dispensing Study for a New Study Lens

Dispensing Study for The Phenacite Project

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02642991
Enrollment
44
Registered
2015-12-30
Start date
2015-11-30
Completion date
2016-03-31
Last updated
2020-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

This study investigated the performance criteria over one week of daily wear to determine if the comfilcon A asphere lens (test) performed equivalently to the comfilcon A sphere (control) in terms of measurement and subjective ratings of visual performance.

Detailed description

This study was a prospective, single site, daily wear, double masked, randomized bilateral cross over dispensing study of binocular wear of comfilcon A asphere lens (test) and comfilcon A sphere lens (control) over 1 week of daily wear.

Interventions

DEVICEPhenacite

contact lens

DEVICEcomfilcon A

contact lens

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

A person is eligible for inclusion in the study if he/she: * Oculo-visual examination in the last two years * Between 18 and 35 years of age and has full legal capacity to volunteer * Has read and understood the informed consent letter * Is willing and able to follow instructions and maintain the appointment schedule * Is correctable to a visual acuity of 20/25 or better (in each eye) with their habitual correction or 20/20 best corrected * Currently wears, or has previously successfully worn, soft contact lenses between -1.00D (Diopoter) and -4.00D * Spherical Contact Lens Rx between -1.00 and -4.00 and spectacle cylinder \<-0.75 * Has not worn lenses for at least 12 hours before the initial visit * Has a subjective response at baseline, which indicates suitability for this study * Currently spends a minimum of 4 hours a day; 5 days a week on digital devices and can replicate this time during the study period * Is willing and able to wear the study contact lenses a minimum of 10 hours per day; 5 days a week

Exclusion criteria

A person will be excluded from the study if he/she: * Has never worn contact lenses before * Any systemic disease affecting ocular health * Is using any systemic or topical medications that will affect ocular health * Has known sensitivity to the diagnostic pharmaceuticals or study products used in this study. * Has any ocular pathology or anomaly that would affect the wearing of the lenses * Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye * Is aphakic * Has anisometropia of \>1.00 * Has undergone corneal refractive surgery * Has strabismus * Has any ocular amblyopia \>= 1line of HC (High Contrast) Visual Acuity * Is participating in any other type of eye related clinical or research study * Has previously participated in study of the Phenacite lenses

Design outcomes

Primary

MeasureTime frameDescription
Distance Visual Acuity (VA) - High IlluminationBaseline (after 10 minutes of lens dispense)Distance visual acuity High Illumination was assessed using logMAR
Near Visual Acuity (VA) - High IlluminationBaseline (after 10 minutes of lens dispense)Near Visual Acuity (VA) - High Illumination assessed using logMAR
Distance Visual Acuity (VA) - Low IlluminationBaseline (after 10 minutes of lens dispense)Distance Visual Acuity (VA) - Low Illumination assessed using logMAR
Near Visual Acuity (VA) - Low IlluminationBaseline (after 10 minutes of lens dispense)Near Visual Acuity (VA) - Low illumination assessed using logMAR
Quality of Distance VisionBaseline (after 10 minutes of lens dispense)Subjective scoring of Quality of Distance Vision assessed using 0-100 continuous scale: (0=extremely poor vision all of the time. 100=excellent vision all of the time)
Quality of Near VisionBaseline (After 10 minutes of lens dispense)Patient subjective scoring for quality of near vision using 0-100 continuous scale: 0=extremely poor vision all of the time. 100=excellent vision all of the time
Quality of Vision With Digital Device UseBaseline (After 10 minutes of lens dispense)Subjective scoring of Quality of Vision with digital device use assessed using 0-100 continuous scale: (0=extremely poor vision all of the time. 100=excellent vision all of the time)
Quality of Intermediate VisionBaseline (After 10 minutes of lens dispense)Subjective scoring of Quality of Intermediate Vision assessed using 0-100 continuous scale: (0=extremely poor vision all of the time. 100=excellent vision all of the time)
Overall Vision QualityBaseline (After 10 minutes of lens dispense)Subjective scoring of overall vision quality assessed using 0-100 continuous scale: (0=extremely poor vision all of the time. 100=excellent vision all of the time)

Secondary

MeasureTime frameDescription
Subjective Ratings of Change in Severity of Tiredness1 weekSubjective rating of change in eye fatigue severity of tiredness assessed using Eye fatigue Experience Questionnaire (EFEG)
Subjective Ratings of Change in Bothersome Rating for Tiredness1 weekSubjective rating of change in eye fatigue bothersome rating for tiredness assessed using Eye fatigue Experience Questionnaire (EFEG)
Subjective Ratings of Change in Frequency of Dryness1 weekSubjective rating of change in eye fatigue frequency of dryness assessed using Eye fatigue Experience Questionnaire (EFEG)
Subjective Ratings of Change in Severity of Dryness1 weekSubjective rating of change in eye fatigue severity of dryness assessed using Eye fatigue Experience Questionnaire (EFEG)
Subjective Ratings of Change in Bothersome Rating of Dryness1 weekSubjective rating of change in eye fatigue bothersome rating for dryness assessed using Eye fatigue Experience Questionnaire (EFEG)
Biomicroscopy Findings - Bulbar Hyperemia1 weekBulbar hyperemia assessment using 5 categories: (0=None, 1= Slight injection to conjunctival vessels, 2= Mild injection, 3= Moderate injection, 4= Severe injection) in (0.25 steps)
Subjective Questionnaire Response - Eye Feel Good1 weekSubjective questionnaire response for These lenses make my eyes feel good - Agree, Disagree
Subjective Questionnaire Response - Eye Feel Relaxed1 weekSubjective questionnaire response for These lenses make my eyes feel relaxed - Agree, Disagree
Subjective Questionnaire Response - Vision1 weekSubjective questionnaire response for These lenses help my vision - Agree, Disagree
Subjective Questionnaire Response - Eye Tired1 weekSubjective questionnaire response for These lenses make my eyes feel less tired - Agree, Disagree
Subjective Questionnaire Response - Eye Strain1 weekSubjective questionnaire response for My eyes don't feel strained while wearing these lenses - Agree, Disagree
Biomicroscopy Findings- Limbal Hyperemia1 weekInvestigator assessment using 5 categories: (0=None, 1= Slight injection to conjunctival vessels, 2= Mild injection, 3= Moderate injection, 4= Severe injection) in (0.25 steps)
Biomicroscopy Findings - Corneal Staining Extent1 weekInvestigator Assessment on Biomicroscopy Findings - Corneal Staining Extent on a scale of 0-4 : 0=No staining, 1=1-15% of area, 2=16-30% of area, 3=31-45% of area, 4= \>45% of area
Ghosting - Distance Vision1 weekPatient subjective scoring using 0-100 continuous scale:0=Intolerable;100=Not noticable
Ghosting - Near Vision1 weekPatient subjective scoring using 0-100 continuous scale:0=Intolerable;100=Not noticable
Overall ComfortBaseline (After 10 minutes of lens dispense)Patient subjective scoring using 0-100 continuous scale, 0= cannot be worn, 100= cannot be felt ever.
Overall DrynessBaseline (after 10 minutes of lens dispense)Patient subjective scoring for overall dryness using 0-100 continuous scale, 0=cannot be worn, 100=no dryness experienced at any time.
Lens Preference - Overall Vision Preference1 weekSubjective rating of lens preference for overall vision preference (Phenacite, comfilcon A, No preference)
Subjective Ratings of Change in Frequency of Tiredness1 weekSubjective rating of change in eye fatigue frequency of tiredness assessed using Eye fatigue Experience Questionnaire (EFEG)

Countries

Canada, United States

Participant flow

Participants by arm

ArmCount
Overall Study
Subjects were randomized to wear phenacite study lens and comfilcon A control lens for one week.
44
Total44

Baseline characteristics

CharacteristicOverall Study
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
44 Participants
Age, Continuous23.1 years
STANDARD_DEVIATION 3.5
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Canada
16 participants
Region of Enrollment
United States
28 participants
Sex: Female, Male
Female
34 Participants
Sex: Female, Male
Male
10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 440 / 44
other
Total, other adverse events
0 / 440 / 44
serious
Total, serious adverse events
0 / 440 / 44

Outcome results

Primary

Distance Visual Acuity (VA) - High Illumination

Distance visual acuity High Illumination was assessed using logMAR

Time frame: 1 week

ArmMeasureGroupValue (MEAN)Dispersion
Phenacite Test LensDistance Visual Acuity (VA) - High IlluminationMonocular-0.10 logMARStandard Deviation 0.08
Phenacite Test LensDistance Visual Acuity (VA) - High IlluminationBinocular-0.15 logMARStandard Deviation 0.07
Comfilcon A Control LensDistance Visual Acuity (VA) - High IlluminationMonocular-0.11 logMARStandard Deviation 0.08
Comfilcon A Control LensDistance Visual Acuity (VA) - High IlluminationBinocular-0.16 logMARStandard Deviation 0.06
Primary

Distance Visual Acuity (VA) - High Illumination

Distance visual acuity High Illumination was assessed using logMAR

Time frame: Baseline (after 10 minutes of lens dispense)

ArmMeasureGroupValue (MEAN)Dispersion
Phenacite Test LensDistance Visual Acuity (VA) - High IlluminationMonocular-0.10 logMARStandard Deviation 0.07
Phenacite Test LensDistance Visual Acuity (VA) - High IlluminationBinocular-0.15 logMARStandard Deviation 0.06
Comfilcon A Control LensDistance Visual Acuity (VA) - High IlluminationMonocular-0.11 logMARStandard Deviation 0.08
Comfilcon A Control LensDistance Visual Acuity (VA) - High IlluminationBinocular-0.17 logMARStandard Deviation 0.07
Primary

Distance Visual Acuity (VA) - Low Illumination

Distance Visual Acuity (VA) - Low Illumination assessed using logMAR

Time frame: 1 week

ArmMeasureGroupValue (MEAN)Dispersion
Phenacite Test LensDistance Visual Acuity (VA) - Low IlluminationMonocular0.06 logMARStandard Deviation 0.08
Phenacite Test LensDistance Visual Acuity (VA) - Low IlluminationBinocular-0.01 logMARStandard Deviation 0.06
Comfilcon A Control LensDistance Visual Acuity (VA) - Low IlluminationMonocular0.05 logMARStandard Deviation 0.1
Comfilcon A Control LensDistance Visual Acuity (VA) - Low IlluminationBinocular0.01 logMARStandard Deviation 0.07
Primary

Distance Visual Acuity (VA) - Low Illumination

Distance Visual Acuity (VA) - Low Illumination assessed using logMAR

Time frame: Baseline (after 10 minutes of lens dispense)

ArmMeasureGroupValue (MEAN)Dispersion
Phenacite Test LensDistance Visual Acuity (VA) - Low IlluminationMonocular0.07 logMARStandard Deviation 0.08
Phenacite Test LensDistance Visual Acuity (VA) - Low IlluminationBinocular0.02 logMARStandard Deviation 0.06
Comfilcon A Control LensDistance Visual Acuity (VA) - Low IlluminationMonocular0.05 logMARStandard Deviation 0.08
Comfilcon A Control LensDistance Visual Acuity (VA) - Low IlluminationBinocular0.00 logMARStandard Deviation 0.06
Primary

Near Visual Acuity (VA) - High Illumination

Near Visual Acuity (VA) - High Illumination assessed using logMAR

Time frame: Baseline (after 10 minutes of lens dispense)

ArmMeasureGroupValue (MEAN)Dispersion
Phenacite Test LensNear Visual Acuity (VA) - High IlluminationMonocular-0.07 logMARStandard Deviation 0.09
Phenacite Test LensNear Visual Acuity (VA) - High IlluminationBinocular-0.13 logMARStandard Deviation 0.09
Comfilcon A Control LensNear Visual Acuity (VA) - High IlluminationMonocular-0.08 logMARStandard Deviation 0.08
Comfilcon A Control LensNear Visual Acuity (VA) - High IlluminationBinocular-0.14 logMARStandard Deviation 0.08
Primary

Near Visual Acuity (VA) - High Illumination

Near Visual Acuity (VA) - High Illumination assessed using logMAR

Time frame: 1 week

ArmMeasureGroupValue (MEAN)Dispersion
Phenacite Test LensNear Visual Acuity (VA) - High IlluminationMonocular-0.06 logMARStandard Deviation 0.1
Phenacite Test LensNear Visual Acuity (VA) - High IlluminationBinocular-0.11 logMARStandard Deviation 0.09
Comfilcon A Control LensNear Visual Acuity (VA) - High IlluminationMonocular-0.07 logMARStandard Deviation 0.09
Comfilcon A Control LensNear Visual Acuity (VA) - High IlluminationBinocular-0.13 logMARStandard Deviation 0.1
Primary

Near Visual Acuity (VA) - Low Illumination

Near Visual Acuity (VA) - Low illumination assessed using logMAR

Time frame: 1 week

ArmMeasureGroupValue (MEAN)Dispersion
Phenacite Test LensNear Visual Acuity (VA) - Low IlluminationMonocular0.16 logMARStandard Deviation 0.17
Phenacite Test LensNear Visual Acuity (VA) - Low IlluminationBinocular0.09 logMARStandard Deviation 0.16
Comfilcon A Control LensNear Visual Acuity (VA) - Low IlluminationMonocular0.18 logMARStandard Deviation 0.17
Comfilcon A Control LensNear Visual Acuity (VA) - Low IlluminationBinocular0.11 logMARStandard Deviation 0.17
Primary

Near Visual Acuity (VA) - Low Illumination

Near Visual Acuity (VA) - Low illumination assessed using logMAR

Time frame: Baseline (after 10 minutes of lens dispense)

ArmMeasureGroupValue (MEAN)Dispersion
Phenacite Test LensNear Visual Acuity (VA) - Low IlluminationMonocular0.15 logMARStandard Deviation 0.16
Phenacite Test LensNear Visual Acuity (VA) - Low IlluminationBinocular0.10 logMARStandard Deviation 0.16
Comfilcon A Control LensNear Visual Acuity (VA) - Low IlluminationMonocular0.14 logMARStandard Deviation 0.15
Comfilcon A Control LensNear Visual Acuity (VA) - Low IlluminationBinocular0.08 logMARStandard Deviation 0.15
Primary

Overall Vision Quality

Subjective scoring of overall vision quality assessed using 0-100 continuous scale: (0=extremely poor vision all of the time. 100=excellent vision all of the time)

Time frame: 1 week

ArmMeasureValue (MEAN)Dispersion
Phenacite Test LensOverall Vision Quality88 units on a scaleStandard Deviation 15
Comfilcon A Control LensOverall Vision Quality89 units on a scaleStandard Deviation 12
Primary

Overall Vision Quality

Subjective scoring of overall vision quality assessed using 0-100 continuous scale: (0=extremely poor vision all of the time. 100=excellent vision all of the time)

Time frame: Baseline (After 10 minutes of lens dispense)

ArmMeasureValue (MEAN)Dispersion
Phenacite Test LensOverall Vision Quality95 units on a scaleStandard Deviation 6
Comfilcon A Control LensOverall Vision Quality89 units on a scaleStandard Deviation 13
Primary

Quality of Distance Vision

Subjective scoring of Quality of Distance Vision assessed using 0-100 continuous scale: (0=extremely poor vision all of the time. 100=excellent vision all of the time)

Time frame: Baseline (after 10 minutes of lens dispense)

ArmMeasureValue (MEAN)Dispersion
Phenacite Test LensQuality of Distance Vision91 units on a scaleStandard Deviation 9
Comfilcon A Control LensQuality of Distance Vision88 units on a scaleStandard Deviation 15
Primary

Quality of Distance Vision

Subjective scoring of Quality of Distance Vision assessed using 0-100 continuous scale: (0=extremely poor vision all of the time. 100=excellent vision all of the time)

Time frame: 1 week

ArmMeasureValue (MEAN)Dispersion
Phenacite Test LensQuality of Distance Vision87 units on a scaleStandard Deviation 16
Comfilcon A Control LensQuality of Distance Vision90 units on a scaleStandard Deviation 12
Primary

Quality of Intermediate Vision

Subjective scoring of Quality of Intermediate Vision assessed using 0-100 continuous scale: (0=extremely poor vision all of the time. 100=excellent vision all of the time)

Time frame: Baseline (After 10 minutes of lens dispense)

ArmMeasureValue (MEAN)Dispersion
Phenacite Test LensQuality of Intermediate Vision97 units on a scaleStandard Deviation 6
Comfilcon A Control LensQuality of Intermediate Vision93 units on a scaleStandard Deviation 9
Primary

Quality of Intermediate Vision

Subjective scoring of Quality of Intermediate Vision assessed using 0-100 continuous scale: (0=extremely poor vision all of the time. 100=excellent vision all of the time)

Time frame: 1 week

ArmMeasureValue (MEAN)Dispersion
Phenacite Test LensQuality of Intermediate Vision92 units on a scaleStandard Deviation 11
Comfilcon A Control LensQuality of Intermediate Vision92 units on a scaleStandard Deviation 10
Primary

Quality of Near Vision

Patient subjective scoring for quality of near vision using 0-100 continuous scale: 0=extremely poor vision all of the time. 100=excellent vision all of the time

Time frame: 1 week

ArmMeasureValue (MEAN)Dispersion
Phenacite Test LensQuality of Near Vision90 units on a scaleStandard Deviation 12
Comfilcon A Control LensQuality of Near Vision90 units on a scaleStandard Deviation 12
Primary

Quality of Near Vision

Patient subjective scoring for quality of near vision using 0-100 continuous scale: 0=extremely poor vision all of the time. 100=excellent vision all of the time

Time frame: Baseline (After 10 minutes of lens dispense)

ArmMeasureValue (MEAN)Dispersion
Phenacite Test LensQuality of Near Vision94 units on a scaleStandard Deviation 8
Comfilcon A Control LensQuality of Near Vision91 units on a scaleStandard Deviation 11
Primary

Quality of Vision With Digital Device Use

Subjective scoring of Quality of Vision with digital device use assessed using 0-100 continuous scale: (0=extremely poor vision all of the time. 100=excellent vision all of the time)

Time frame: Baseline (After 10 minutes of lens dispense)

ArmMeasureValue (MEAN)Dispersion
Phenacite Test LensQuality of Vision With Digital Device Use96 units on a scaleStandard Deviation 8
Comfilcon A Control LensQuality of Vision With Digital Device Use94 units on a scaleStandard Deviation 7
Primary

Quality of Vision With Digital Device Use

Subjective scoring of Quality of Vision with digital device use assessed using 0-100 continuous scale: (0=extremely poor vision all of the time. 100=excellent vision all of the time)

Time frame: 1 week

ArmMeasureValue (MEAN)Dispersion
Phenacite Test LensQuality of Vision With Digital Device Use91 units on a scaleStandard Deviation 13
Comfilcon A Control LensQuality of Vision With Digital Device Use90 units on a scaleStandard Deviation 12
Secondary

Biomicroscopy Findings - Bulbar Hyperemia

Bulbar hyperemia assessment using 5 categories: (0=None, 1= Slight injection to conjunctival vessels, 2= Mild injection, 3= Moderate injection, 4= Severe injection) in (0.25 steps)

Time frame: 1 week

ArmMeasureValue (MEAN)Dispersion
Phenacite Test LensBiomicroscopy Findings - Bulbar Hyperemia1.24 units on a scaleStandard Deviation 0.67
Comfilcon A Control LensBiomicroscopy Findings - Bulbar Hyperemia1.37 units on a scaleStandard Deviation 0.82
Secondary

Biomicroscopy Findings - Corneal Staining Extent

Investigator Assessment on Biomicroscopy Findings - Corneal Staining Extent on a scale of 0-4 : 0=No staining, 1=1-15% of area, 2=16-30% of area, 3=31-45% of area, 4= \>45% of area

Time frame: 1 week

ArmMeasureGroupValue (MEAN)Dispersion
Phenacite Test LensBiomicroscopy Findings - Corneal Staining ExtentNasal0.14 units on a scaleStandard Deviation 0.34
Phenacite Test LensBiomicroscopy Findings - Corneal Staining ExtentSuperior0.13 units on a scaleStandard Deviation 0.37
Phenacite Test LensBiomicroscopy Findings - Corneal Staining ExtentTemporal0.07 units on a scaleStandard Deviation 0.26
Phenacite Test LensBiomicroscopy Findings - Corneal Staining ExtentInferior0.34 units on a scaleStandard Deviation 0.58
Phenacite Test LensBiomicroscopy Findings - Corneal Staining ExtentCentral0.05 units on a scaleStandard Deviation 0.21
Comfilcon A Control LensBiomicroscopy Findings - Corneal Staining ExtentInferior0.51 units on a scaleStandard Deviation 0.74
Comfilcon A Control LensBiomicroscopy Findings - Corneal Staining ExtentCentral0.10 units on a scaleStandard Deviation 0.34
Comfilcon A Control LensBiomicroscopy Findings - Corneal Staining ExtentNasal0.16 units on a scaleStandard Deviation 0.39
Comfilcon A Control LensBiomicroscopy Findings - Corneal Staining ExtentTemporal0.03 units on a scaleStandard Deviation 0.2
Comfilcon A Control LensBiomicroscopy Findings - Corneal Staining ExtentSuperior0.19 units on a scaleStandard Deviation 0.4
Secondary

Biomicroscopy Findings- Limbal Hyperemia

Investigator assessment using 5 categories: (0=None, 1= Slight injection to conjunctival vessels, 2= Mild injection, 3= Moderate injection, 4= Severe injection) in (0.25 steps)

Time frame: 1 week

ArmMeasureValue (MEAN)Dispersion
Phenacite Test LensBiomicroscopy Findings- Limbal Hyperemia0.98 units on a scaleStandard Deviation 0.69
Comfilcon A Control LensBiomicroscopy Findings- Limbal Hyperemia1.21 units on a scaleStandard Deviation 0.89
Secondary

Ghosting - Distance Vision

Patient subjective scoring using 0-100 continuous scale:0=Intolerable;100=Not noticable

Time frame: 1 week

ArmMeasureValue (MEAN)Dispersion
Phenacite Test LensGhosting - Distance Vision93 units on a scaleStandard Deviation 12
Comfilcon A Control LensGhosting - Distance Vision93 units on a scaleStandard Deviation 12
Secondary

Ghosting - Near Vision

Patient subjective scoring using 0-100 continuous scale:0=Intolerable;100=Not noticable

Time frame: 1 week

ArmMeasureValue (MEAN)Dispersion
Phenacite Test LensGhosting - Near Vision93 units on a scaleStandard Deviation 10
Comfilcon A Control LensGhosting - Near Vision93 units on a scaleStandard Deviation 10
Secondary

Lens Preference - Overall Vision Preference

Subjective rating of lens preference for overall vision preference (Phenacite, comfilcon A, No preference)

Time frame: 1 week

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Phenacite Test LensLens Preference - Overall Vision PreferencePhenacite14 Participants
Phenacite Test LensLens Preference - Overall Vision Preferencecomfilcon A25 Participants
Phenacite Test LensLens Preference - Overall Vision PreferenceNo Preference5 Participants
Secondary

Overall Comfort

Patient subjective scoring using 0-100 continuous scale, 0= cannot be worn, 100= cannot be felt ever.

Time frame: Baseline (After 10 minutes of lens dispense)

ArmMeasureValue (MEAN)Dispersion
Phenacite Test LensOverall Comfort91 units on a scaleStandard Deviation 8
Comfilcon A Control LensOverall Comfort89 units on a scaleStandard Deviation 12
Secondary

Overall Comfort

Patient subjective scoring for overall comfort using 0-100 continuous scale, 0= cannot be worn, 100= cannot be felt ever.

Time frame: 1 week

ArmMeasureValue (MEAN)Dispersion
Phenacite Test LensOverall Comfort78 units on a scaleStandard Deviation 23
Comfilcon A Control LensOverall Comfort79 units on a scaleStandard Deviation 19
Secondary

Overall Dryness

Patient subjective scoring for overall dryness using 0-100 continuous scale, 0=cannot be worn, 100=no dryness experienced at any time.

Time frame: Baseline (after 10 minutes of lens dispense)

ArmMeasureValue (MEAN)Dispersion
Phenacite Test LensOverall Dryness92 units on a scaleStandard Deviation 12
Comfilcon A Control LensOverall Dryness92 units on a scaleStandard Deviation 12
Secondary

Overall Dryness

Patient subjective scoring for overall dryness using 0-100 continuous scale, 0=cannot be worn, 100=no dryness experienced at any time.

Time frame: 1 week

ArmMeasureValue (MEAN)Dispersion
Phenacite Test LensOverall Dryness76 units on a scaleStandard Deviation 23
Comfilcon A Control LensOverall Dryness77 units on a scaleStandard Deviation 21
Secondary

Subjective Questionnaire Response - Eye Feel Good

Subjective questionnaire response for These lenses make my eyes feel good - Agree, Disagree

Time frame: 1 week

ArmMeasureGroupValue (NUMBER)
Phenacite Test LensSubjective Questionnaire Response - Eye Feel GoodAgree86 percentage of participants
Phenacite Test LensSubjective Questionnaire Response - Eye Feel GoodDisagree14 percentage of participants
Comfilcon A Control LensSubjective Questionnaire Response - Eye Feel GoodDisagree29 percentage of participants
Comfilcon A Control LensSubjective Questionnaire Response - Eye Feel GoodAgree71 percentage of participants
Secondary

Subjective Questionnaire Response - Eye Feel Relaxed

Subjective questionnaire response for These lenses make my eyes feel relaxed - Agree, Disagree

Time frame: 1 week

ArmMeasureGroupValue (NUMBER)
Phenacite Test LensSubjective Questionnaire Response - Eye Feel RelaxedAgree79 percentage of participants
Phenacite Test LensSubjective Questionnaire Response - Eye Feel RelaxedDisagree21 percentage of participants
Comfilcon A Control LensSubjective Questionnaire Response - Eye Feel RelaxedAgree79 percentage of participants
Comfilcon A Control LensSubjective Questionnaire Response - Eye Feel RelaxedDisagree21 percentage of participants
Secondary

Subjective Questionnaire Response - Eye Strain

Subjective questionnaire response for My eyes don't feel strained while wearing these lenses - Agree, Disagree

Time frame: 1 week

ArmMeasureGroupValue (NUMBER)
Phenacite Test LensSubjective Questionnaire Response - Eye StrainAgree75 percentage of participants
Phenacite Test LensSubjective Questionnaire Response - Eye StrainDisagree25 percentage of participants
Comfilcon A Control LensSubjective Questionnaire Response - Eye StrainAgree75 percentage of participants
Comfilcon A Control LensSubjective Questionnaire Response - Eye StrainDisagree25 percentage of participants
Secondary

Subjective Questionnaire Response - Eye Tired

Subjective questionnaire response for These lenses make my eyes feel less tired - Agree, Disagree

Time frame: 1 week

ArmMeasureGroupValue (NUMBER)
Phenacite Test LensSubjective Questionnaire Response - Eye TiredAgree82 percentage of participants
Phenacite Test LensSubjective Questionnaire Response - Eye TiredDisagree18 percentage of participants
Comfilcon A Control LensSubjective Questionnaire Response - Eye TiredAgree75 percentage of participants
Comfilcon A Control LensSubjective Questionnaire Response - Eye TiredDisagree25 percentage of participants
Secondary

Subjective Questionnaire Response - Vision

Subjective questionnaire response for These lenses help my vision - Agree, Disagree

Time frame: 1 week

ArmMeasureGroupValue (NUMBER)
Phenacite Test LensSubjective Questionnaire Response - VisionAgree96 percentage of participants
Phenacite Test LensSubjective Questionnaire Response - VisionDisagree4 percentage of participants
Comfilcon A Control LensSubjective Questionnaire Response - VisionAgree96 percentage of participants
Comfilcon A Control LensSubjective Questionnaire Response - VisionDisagree4 percentage of participants
Secondary

Subjective Ratings of Change in Bothersome Rating for Tiredness

Subjective rating of change in eye fatigue bothersome rating for tiredness assessed using Eye fatigue Experience Questionnaire (EFEG)

Time frame: 1 week

ArmMeasureGroupValue (NUMBER)
Phenacite Test LensSubjective Ratings of Change in Bothersome Rating for TirednessMuch Better20 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Bothersome Rating for TirednessWorse0 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Bothersome Rating for TirednessNo Difference35 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Bothersome Rating for TirednessMuch Worse0 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Bothersome Rating for TirednessBetter45 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Bothersome Rating for TirednessMuch Worse0 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Bothersome Rating for TirednessBetter45 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Bothersome Rating for TirednessMuch Better10 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Bothersome Rating for TirednessNo Difference40 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Bothersome Rating for TirednessWorse5 percentage of participants
Secondary

Subjective Ratings of Change in Bothersome Rating of Dryness

Subjective rating of change in eye fatigue bothersome rating for dryness assessed using Eye fatigue Experience Questionnaire (EFEG)

Time frame: 1 week

ArmMeasureGroupValue (NUMBER)
Phenacite Test LensSubjective Ratings of Change in Bothersome Rating of DrynessBetter40 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Bothersome Rating of DrynessWorse15 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Bothersome Rating of DrynessNo Difference25 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Bothersome Rating of DrynessMuch Worse5 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Bothersome Rating of DrynessMuch Better15 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Bothersome Rating of DrynessMuch Worse5 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Bothersome Rating of DrynessMuch Better10 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Bothersome Rating of DrynessBetter40 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Bothersome Rating of DrynessNo Difference25 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Bothersome Rating of DrynessWorse20 percentage of participants
Secondary

Subjective Ratings of Change in Frequency of Dryness

Subjective rating of change in eye fatigue frequency of dryness assessed using Eye fatigue Experience Questionnaire (EFEG)

Time frame: 1 week

ArmMeasureGroupValue (NUMBER)
Phenacite Test LensSubjective Ratings of Change in Frequency of DrynessNo Difference25 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Frequency of DrynessWorse15 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Frequency of DrynessMuch Better15 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Frequency of DrynessMuch Worse10 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Frequency of DrynessBetter35 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Frequency of DrynessMuch Worse5 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Frequency of DrynessBetter15 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Frequency of DrynessNo Difference35 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Frequency of DrynessWorse25 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Frequency of DrynessMuch Better20 percentage of participants
Secondary

Subjective Ratings of Change in Frequency of Tiredness

Subjective rating of change in eye fatigue frequency of tiredness assessed using Eye fatigue Experience Questionnaire (EFEG)

Time frame: 1 week

ArmMeasureGroupValue (NUMBER)
Phenacite Test LensSubjective Ratings of Change in Frequency of TirednessBetter50 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Frequency of TirednessWorse0 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Frequency of TirednessNo Difference36 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Frequency of TirednessMuch Worse4 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Frequency of TirednessMuch Better11 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Frequency of TirednessMuch Worse0 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Frequency of TirednessMuch Better18 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Frequency of TirednessBetter39 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Frequency of TirednessNo Difference39 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Frequency of TirednessWorse4 percentage of participants
Secondary

Subjective Ratings of Change in Severity of Dryness

Subjective rating of change in eye fatigue severity of dryness assessed using Eye fatigue Experience Questionnaire (EFEG)

Time frame: 1 week

ArmMeasureGroupValue (NUMBER)
Phenacite Test LensSubjective Ratings of Change in Severity of DrynessBetter41 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Severity of DrynessWorse9 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Severity of DrynessNo Difference32 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Severity of DrynessMuch Worse9 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Severity of DrynessMuch Better9 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Severity of DrynessMuch Worse5 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Severity of DrynessMuch Better5 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Severity of DrynessBetter41 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Severity of DrynessNo Difference27 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Severity of DrynessWorse23 percentage of participants
Secondary

Subjective Ratings of Change in Severity of Tiredness

Subjective rating of change in eye fatigue severity of tiredness assessed using Eye fatigue Experience Questionnaire (EFEG)

Time frame: 1 week

ArmMeasureGroupValue (NUMBER)
Phenacite Test LensSubjective Ratings of Change in Severity of TirednessBetter48 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Severity of TirednessWorse4 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Severity of TirednessNo Difference26 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Severity of TirednessMuch Worse4 percentage of participants
Phenacite Test LensSubjective Ratings of Change in Severity of TirednessMuch Better17 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Severity of TirednessMuch Worse0 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Severity of TirednessMuch Better17 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Severity of TirednessBetter39 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Severity of TirednessNo Difference35 percentage of participants
Comfilcon A Control LensSubjective Ratings of Change in Severity of TirednessWorse9 percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026